Global Gynecological Devices Market Size

Gynecological Devices Market Analysis

The gynecological devices market is expected to register a CAGR of 4% over the forecast period.

COVID-19 had a significant impact on the overall healthcare industry including the gynecological devices market. For instance, as per the article published in December 2021 under the title 'Effects of the COVID-19 pandemic on obstetrics and gynecology residency training in Turkey', important interventions in obstetrics and gynecology, such as emergent cesarean section or labor, make obstetrics and gynecology an emergent department. The trainees had to utilize gynecological devices and endoscopes as a part of their procedures. Therefore, when dealing with emergent interventions, trainees were faced with the risk of virus contamination from asymptomatic COVID-19 cases. Even with well-equipped or qualified workers, interventions might go wrong when there was high stress during obstetrics and gynecological care. Furthermore, as per the article published in January 2022 under the title 'Laparoscopic gynecological surgery in COVID-19 pandemic', for some urgent treatments, like ruptured ectopic pregnancy and ovarian torsion, laparoscopy is the best option. But there are some concerns among surgeons everywhere about the potential for SARS-CoV-2 transmission through the development of a pneumoperitoneum during laparoscopy. Hence COVID-19 had a significant impact on the gynecological devices market.

An increase in gynecological disorders, such as ovarian cancer, cervical cancer, uterine cancer, vaginal cancer, and vulvar cancer, is driving the market for gynecological devices across the world. The American Cancer Society 2022 update stated that the average age of endometrial cancer diagnosis in women is 60, whereas it isn't common amongst women below the age of 45. Furthermore, about 65,950 new cases of cancer of the body of the uterus (uterine body or corpus) were diagnosed in 2022 in the United States. These estimates include both endometrial cancers and uterine sarcomas. Up to 10% of uterine body cancers are sarcomas, so the actual numbers for endometrial cancer cases and deaths are slightly lower than these estimates.

In addition, The World Health Organization 2022 update stated that, with an anticipated 604,000 new cases in 2020, cervical cancer is the fourth most common malignancy in women worldwide. 90% of the anticipated 342,000 cervical cancer deaths in 2020 took place in low- and middle-income nations. The high mortality rate from cancer could be reduced through a comprehensive approach that includes prevention, early diagnosis, effective screening, and treatment programs. This, in turn, leads to high demand for gynecological devices globally. Furthermore, the increased awareness regarding gynecological health is a major fuelling factor for the market growth. For instance, in September 2022, the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research is presenting the 'Virtual Ovarian Cancer Research Series'. The goal of the seminar series is to bring together clinicians and researchers from across many disciplines and institutions worldwide to share ideas and advance the field of ovarian cancer research.

Hence as per the factors mentioned above, the gynecological devices market is likely to grow over the forecast period. However, stringent regulatory guidelines relating to the devices restrain the market growth.